J&J's fa­vorite CAR-T de­vel­op­er, cur­rent­ly owned by a Chi­nese CRO, is lay­ing the ground­work for US IPO

Gen­Script, the low-pro­file own­er of CAR-T dark horse Nan­jing Leg­end Biotech, is hatch­ing a plan to spin out its fa­mous sub­sidiary and shoot for a US IPO.

The con­tract re­search or­ga­ni­za­tion dis­closed its pro­pos­al in a fil­ing to the Hong Kong Stock Ex­change, where it’s been list­ed since late 2015. With the HKEX’s bless­ing, Leg­end Biotech has sub­mit­ted a draft reg­is­tra­tion state­ment to the SEC, it wrote.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.